CooperSurgical to acquire the Cook Medical’s Reproductive Health division

Article

CooperSurgical, Inc, a global provider of health products for women, babies, and families, announced Monday plans to acquire the Reproductive Health division of Cook Medical, a manufacturer for minimally invasive medical devices in the fertility, obstetrics, and gynecology markets.

Cook Medical’s Reproductive Health sector produced annual revenues of $158 million in 2021, a year-over-year increase of 17%. The acquisition will allow for the expansion and leverage of CooperSurgical’s fertility, labor & delivery offerings across Asia-Pacific countries, where the company estimates approximately 50% of new fertility clinic builds in 2022 will take place. Cook’s well-established devices will strengthen Cooper’s growing portfolio and include fertility products such as needles, pipettes, catheters, and equipment. Cooper’s obstetric and gynecological products include devices for vacuum-assisted delivery, fetal monitoring, infant critical care, and cord blood and tissue storage.

The decision also allows Cooper to potentially leverage Costa Rica manufacturing facilities, reduce cost, increase efficiencies, and add more than 100 individuals to the company’s sales force internationally.

Reference

  1. Press release. CooperCompanies to Acquire Cook® Medical’s Reproductive Health Business. Accessed February 10, 2022. https://investor.coopercos.com/static-files/02c9e306-3f90-4926-82ca-09340f3f6323
Recent Videos
JoAnn Pinkerton discusses elinzanetant's crucial role in VMS therapy | Image Credit: uvahealth.com
Empowering women to take charge of their health | Image Credit: © piecesofi.com - © piecesofi.com - stock.adobe.com.
Supporting women through menopause with knowledge and care | Image Credit: © SHOTPRIME STUDIO - © SHOTPRIME STUDIO - stock.adobe.com.
How fezolinetant revolutionizes non-hormonal menopause therapy | Image Credit: imsociety.org
Gulf War exposures linked to early menopause in women veterans | Image Credit: linkedin.com.
Vanessa Muñiz discusses benefits of clinical hypnosis against hot flashes | Image Credit: mindbodymedicine.artsandsciences.baylor.edu
Elinzanetant displays positive phase 3 safety and efficacy data against VMS | Image Credit: © toeytoey - © toeytoey - stock.adobe.com.
© 2024 MJH Life Sciences

All rights reserved.